NICE guidance in schizophrenia: How generalisable are drug trials?
Aims and method: To test the National Institute for Clinical Excellence (NICE) assertion that characteristics of participants in the majority of clinical drug trials in schizophrenia do not reflect clinical practice. In particular they were concerned about the relative exclusion of women, older adul...
第一著者: | Burns, T |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2006
|
類似資料
-
Diagnosis and management of endometriosis: summary of NICE guidance
著者:: Kuznetsov, L, 等
出版事項: (2017) -
NICE guidance to working with real-world data
著者:: A. Sh. Motrinchuk, 等
出版事項: (2023-01-01) -
Commentary: Controversies in NICE guidance on chronic kidney disease.
著者:: Landray, M, 等
出版事項: (2008) -
Management of hip fracture in adults: summary of NICE guidance.
著者:: Ftouh, S, 等
出版事項: (2011) -
Commentary: Controversies in NICE guidance on chronic kidney disease
著者:: Landray, M, 等
出版事項: (2008)